Unlock instant, AI-driven research and patent intelligence for your innovation.

Protein increasing cell infectivity of herpes simplex virus and use thereof

a technology cell infectivity, which is applied in the direction of viruses, peptide/protein ingredients, fusion polypeptides, etc., can solve the problems of weak immunoreactivity, low transduction efficiency of hsv, and limited gene size, so as to increase the cell infectivity of herpes simplex virus

Active Publication Date: 2012-11-27
KOREA INST OF RADIOLOGICAL & MEDICAL SCI
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention is about a new protein called HveA / HVEM that can make herpes simplex virus (HSV) and its fusion protein more infectious. The invention also includes a gene that makes this protein, an expression vector that can carry the gene, and a host cell that can produce the protein. The invention also describes a method for making the protein. This new protein can help researchers better understand how HSV works and may also have potential uses in treating herpes infections.

Problems solved by technology

On the other hand, repeated use of the adenoviral vector may induce strong immunoreactivity, and the size of genes is limited when using the adenoviral vector.
However, since the virus is introduced into cells by an endocytosis instead of by a fusion, the HSV is degradated in the cells, and thus transduction efficiency of the HSV is low.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Protein increasing cell infectivity of herpes simplex virus and use thereof
  • Protein increasing cell infectivity of herpes simplex virus and use thereof
  • Protein increasing cell infectivity of herpes simplex virus and use thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

HSV Infection by sHveA82 and sHveA107

[0058]It was identified whether protein efficiently mediates the entry of a virus into HSV-resistant cells, CHO-K1 cells in the same manner as in Comparative Example 3, except that recombinant sHveA82 protein and recombinant sHveA107 protein were used. In FIG. 7A, the x-axis indicates 500 nM recombinant sHveA proteins, and the number on the y-axis indicates the level of the virus infection. FIG. 7B illustrates infected cells according to the increasing concentrations of sHveA protein.

example 2

Preparation of Recombinant Expression Vector Expressing Anti-CEA scFv-HA82

[0059]An anti-CEA scFv gene was obtained by PCR using a forward primer (SEQ ID NO: 7) and a reverse primer (SEQ ID NO: 8), and using a pre-provided anti-CEA scFv gene as a template. The PCR was performed as follows: 0.1 μg of anti-CEA scFv DNA, 10 pmol of primers (SEQ ID NOS: 7 and 8, respectively), 10 units of Taq polymerase (Takara), 1× buffer solution, and 2.5 mM dNTP were mixed and water was added thereto such that the volume of the mixture was 50 μl. The anti-CEA scFv DNA was amplified by pre-denaturing the template DNA at 95° C. for 5 minutes, performing 30 cycles: at 94° C. for 1 minute, at 60° C. for 1 minute, and at 72° C. for 1 minute, and performing a final extension at 72° C. for 10 minutes. The amplified anti-CEA scFv DNA was isolated using column chromatography. The reverse primer (SEQ ID NO: 8) included a base sequence encoding GGGGS amino acid sequence (SEQ ID NO: 19). In order to insert the a...

example 3

Expression and Purification of Recombinant Anti-CEA scFv-HA82 Protein

[0061]Expression and purification of the recombinant anti-CEA scFv-HA82 protein were performed in the same manner as in Comparative Example 2. As shown in FIG. 4, protein having about 37 kDa of molecular size (lane 2) was isolated and purified.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
sizeaaaaaaaaaa
volumeaaaaaaaaaa
compositionaaaaaaaaaa
Login to View More

Abstract

Provided are an isolated protein derived from an N-terminal of HveA / HVEM and having activity of increasing the cell infectivity of herpes simplex virus (HSV) and use thereof.

Description

BACKGROUND OF THE INVENTION[0001]1. Field of the Invention[0002]The present invention relates to an isolated protein increasing a cell infectivity of herpes simplex virus and use thereof.[0003]This work has been supported in part by research grants from Korean Ministry of Education, Science & Technology [Project No.: M1053040003-08N3404-00310, Title: Cancer gene therapy by targeted HSV-1 development. And Project No.: M20702020001-08N0202-00110, Title: Development of combinational radiotherapeutic agents and validation system.][0004]2. Description of the Related Art[0005]Herpes simplex virus (HSV) which is a DNA virus containing about 150 kb of genome is an enveloped icosahedral virion with a size of about 100 to about 200 nm. HSV enters a cell by attaching glycoprotein B (gB) or glycoprotein C (gC) of its envelope to glycosaminoglycan (GAG) of the surface of the cell, and binding glycoprotein D (gD) of its envelope to various receptors of the surface of the cell to induce fusion of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(United States)
IPC IPC(8): C07K14/03C07K14/00
CPCC07K14/70578C07K16/3007C12N15/87A61K2039/505C07K2317/622C07K2319/00C12N2710/16622
Inventor KWON, HEE CHUNGBAEK, HYUN JUNGLEE, KEE HOKUROKI, MASAHIDE
Owner KOREA INST OF RADIOLOGICAL & MEDICAL SCI